SHREE CEMENT LTD. Q1 FY27 Results

Shree Cement opened FY27 with a volume-led topline but a squeezed bottom line. Consolidated revenue rose 18.0% YoY (2.2% QoQ) to ₹6,233 Cr, yet consolidated PAT fell 17.5% YoY to ₹531 Cr (owners' share ₹529 Cr), essentially flat sequentially (+0.7% QoQ vs Q4's ₹528 Cr). The story is not the topline — it is margin compression: net profit margin dropped to 8.5% from 12.2% a year ago, and the operating margin the company discloses fell to 24% from 30% YoY. EBITDA of ₹1,484 Cr was actually down ~5% YoY despite revenue being 18% higher, which is the clearest signal that cost inflation, not demand, defined the quarter.

The margin bridge sits squarely on input and logistics costs. Power & fuel jumped 25.6% YoY to ₹1,645 Cr, cost of materials consumed rose ~43% to ₹734 Cr, and freight & forwarding climbed ~23% to ₹1,435 Cr — precisely the ₹150–200/tonne fuel-and-packaging headwind management flagged on the Q4 concall (confident tone, cautiously-optimistic near-term). On that count the print confirms rather than contradicts guidance: management warned the near term would be pressured and it was, with the intended price-led offset only partial as margins still contracted. Lower other income (₹212 Cr vs ₹235 Cr YoY) added a small further drag. This broadly matches the sector setup brokerages laid out ahead of the quarter — strong industry volume growth but margins under pressure, with coverage-universe EBITDA/tonne seen down ~14.5% YoY — so the result reads in line with the Street's cement-sector thesis rather than a surprise; no SHREECEM-specific PAT consensus was locatable.

The stock went into the print at ₹26,200, down 0.2% over the past month of trading.

For context: PAT has now risen for 2 consecutive quarters; revenue is at a 6-quarter high.

Standalone tells a harder version of the same story: revenue up 13.6% YoY to ₹5,623 Cr but PAT down 29.2% to ₹438 Cr — a materially steeper profit decline than the consolidated −17.5%, the gap explained by the overseas/UAE subsidiaries (Union Cement and others contributing ~₹610 Cr revenue and ~₹137 Cr net profit) cushioning the group print; readers comparing the two numbers should note the consolidated basis is the milder one. On concurrent corporate actions, the board that approved these results had earlier proposed a ₹70/share final dividend (record date 17 July) and the 47th AGM fell on the results day itself; the balance sheet remains conservative (net worth ₹23,787 Cr, debt-equity 0.07). Against management's FY27 framework — ~40 mt volume target, ₹1,500 Cr capex toward RMC, logistics and the Meghalaya plant, and the 80 mt-by-2029 ambition with profitability prioritised — Q1 shows the profitability side under strain even as the volume engine runs.

Q1 shows strong volume growth (+15% YoY) but severe margin compression (PAT -17.5% despite revenue +18%). Management attributes this to temporary Middle East supply shocks (pet-coke→coal, gypsum shortage, clinker factor drop). Maintains FY27 guidance of 40 MT volumes and ₹1,500 Cr capex. Key risk: trade-sales mix collapse (62% vs 71%) and clinker factor deterioration (1.58→1.50) may be structural, not transient.

Moderate pressure on transparency. Analysts pressed UAE metrics, subsidiary breakdown, RMC profitability; management deflected with 'consolidated focus' and refusal to disaggregate. Defensive on pricing outlook (won't forecast). Accepted cost headwind reality but framed as Q1-specific abnormality; some skepticism on reversal timing.

Score 6/10. Defensive on subsidiary/UAE disclosures ('number game', 'not disclosing'); candid on cost headwinds and Q1 difficulty. Refuses EBITDA projections citing market risk. Repetitive on cost-peak narrative. Met Q1 volume targets (10.5 MT of 40 MT guide = on pace). Capex ₹456 Cr of ₹1,500 Cr = on track. RMC added 8 plants as stated. Prior guidance on 40 MT reaffirmed. Cost peak claim not yet evidenced (PAT -17.5%).

Shree Cement enters Q1 FY-27 in a classic margin squeeze. The company guides for 9–10% volume growth in FY27, anchored on ~40 Mt output, with Q1 expected to track in line with or slightly ahead of Q4 FY-26 (₹6,101 Cr net revenue, 528 Cr PAT). But management flagged INR 150–200 per ton of cost inflation in Q1—primarily coal and petroleum coke, driven by West Asia disruptions. The math is straightforward: volume lifts the top line, but input costs bite margin.

What a strong Q1 looks like: Revenue in-line or above ₹6,100 Cr, volumes up 10%+ YoY, and evidence that the company is holding or recovering margin (PAT margin ≥9%) despite cost inflation—suggests pricing power or tight cost control. What a weak Q1 looks like: Revenue below ₹5,800 Cr, volume growth flat or sub-8%, PAT under ₹250 Cr with margin sub-7%—signals that input cost pressures aren't being passed to the market and inventory take-downs are underway.

Shree Cement guided for 9–10% volume growth and FY27 capex of ~₹1,500 Cr (RMC plants, railway sidings, Meghalaya integrated plant). Q1 is a tone-setter: if volume traction is evident and margin compression is benign (single-digit percentage-point drop YoY), the full-year guide holds. But cement sector consensus expects EBITDA margins to compress ~170 bps YoY due to energy cost inflation—Q1 will confirm whether Shree Cement is in line or outperforming. FY26 saw strong PAT (Q4 alone ₹528 Cr); if Q1 margins are much steeper than the sector average, it signals either cost-control prowess or input cost tailwinds Shree Cement isn't publicly signalling.

Shree Cement is at an inflection: volume growth (9–10% FY27 guide) is the growth story, but Q1 input-cost headwinds (INR 150–200/t) will test whether the company can defend or recover margin. The market is pricing modest upside (7–8% to ₹28,876 target), meaning Q1 results that confirm volume momentum and show margin resilience could lift the stock; misses on either front or further cost guidance revisions lower could disappoint. The AGM on result-day itself is unusual—management will face shareholders on the same day; this suggests confidence in the numbers, but also opportunity for the Street to ask tough questions on capex ROI and cost pass-through into H2 FY27.